No profile data available.
China SXT Pharmaceuticals, Inc. (SXTC) is a healthcare company in the nutritional and natural health products industry, based in Taizhou, China, with about 56 full-time employees.
It reported revenue of $1.74 million for fiscal year 2025, down 9.7% from fiscal year 2024, and net income of -$3.30 million. Its market capitalization was $196,494 as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended March 31, 2025; market data as of October 9, 2026.
, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China.
China SXT Pharmaceuticals reported $1.74 million in revenue for fiscal year 2025, down 9.7% from $1.93 million in fiscal year 2024.
$196,494 as of October 9, 2026.
Listed companies of a similar size in the same industry (nutritional and natural health products) include Cyios Corporation (CYIO), Stemtech Corporation (STEK), BioAdaptives, Inc. (BDPT), Ayujoy Herbals Ltd. (AJOY).